{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021274","form_type":"8-K","ticker":"CELC","cik":"0001603454","company_name":"Celcuity Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.467195+00:00","generated_at":"2026-05-17T23:42:05.451047+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Celcuity launches $150M convertible notes + $75M common stock offerings; also to draw $30M loan","bullets":["Concurrent underwritten offerings: $150M convertible notes due 2031 and $75M common stock; 30-day over-allotment options for additional $22.5M notes and $11.25M stock.","Proceeds to fund capped call transactions (reduce dilution on note conversion) and for working capital, clinical trials, R&D.","Intends to draw $30M Term D Loan in late August 2025 after achieving clinical milestone under existing loan agreement.","Amended loan with Innovatus/Oxford: $25k fee, extended conversion right on Term A loan to $10/share through May 9, 2026.","Preliminary cash at June 30, 2025: ~$168.4M (down from $283.1M a year ago)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021274","json":"https://secwatch.observer/filing/0001641172-25-021274.json","markdown":"https://secwatch.observer/filing/0001641172-25-021274.md","text":"https://secwatch.observer/filing/0001641172-25-021274.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/0001641172-25-021274-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:42:05.451047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}